Market capitalization | SEK1.25b |
Enterprise Value | SEK1.23b |
P/E (TTM) P/E ratio | 31.29 |
EV/Sales (TTM) EV/Sales | 4.86 |
P/S ratio (TTM) P/S ratio | 4.96 |
P/B ratio (TTM) P/B ratio | 7.65 |
Revenue growth (TTM) Revenue growth | 20.41% |
Revenue (TTM) Revenue | SEK253.01m |
EBIT (operating result TTM) EBIT | SEK33.51m |
As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.
1 Analyst has issued a forecast Paxman:
1 Analyst has issued a forecast Paxman:
Dec '24 |
+/-
%
|
||
Revenue | 253 253 |
20%
20%
|
|
Gross Profit | 34 34 |
166%
166%
|
|
EBITDA | 50 50 |
59%
59%
|
EBIT (Operating Income) EBIT | 34 34 |
166%
166%
|
Net Profit | 40 40 |
382%
382%
|
In millions SEK.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Paxman AB engages in the research and development of scalp cooling system. It focuses on its product, PAXMAN Scalp Cooling System, which is used to minimize hair loss in connection with chemotherapy treatment. The company was founded by Glenn Ann Paxman in 1996 and is headquartered in Karlshamn, Sweden.
Head office | Sweden |
CEO | Richard Paxman |
Employees | 105 |
Founded | 2016 |
Website | www.paxman.se |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.